Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Genedrive (GDR) Share News

Genedrive MT-RNR1 ID kit receives final UK NICE recommendation for NHS

30th Mar 2023 11:18

(Alliance News) - Genedrive PLC on Thursday said the UK National Institute for Health & Care Excellence ratified and finalised its recommendation that Genedrive's hearing loss gene screening test MT-RNR1 ID kit can be used by the NHS. Read More

LONDON BRIEFING: Stocks add to rebound; SSE ups earnings guidance

30th Mar 2023 07:57

(Alliance News) - Stocks in London are set to build on Wednesday's gains, as risk appetite recovers following the recent banking turmoil. Read More

AIM WINNERS & LOSERS: Tribal shares drop on NTU contract termination

20th Mar 2023 09:37

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More

Genedrive to roll out hearing loss screening in two NHS sites

20th Mar 2023 09:21

(Alliance News) - Genedrive PLC on Monday reported further progress in the rollout of its hearing loss gene screening test in the UK. Read More

LONDON MARKET OPEN: UBS down 15%, Credit Suisse down 60% after deal

20th Mar 2023 08:53

(Alliance News) - Stock prices in London opened lower on Monday morning as the emergency takeover of beleaguered lender Credit Suisse over the weekend failed to quell market turmoil. Read More

LONDON MARKET MIDDAY: Standard Chartered takeover talks lift FTSE 100

9th Feb 2023 12:05

(Alliance News) - Stock prices in London were largely higher at midday on Thursday, thanks to a strong set of results from drug maker AstraZeneca and renewed takeover talks for lender Standard Chartered. Read More

AIM WINNERS & LOSERS: Zytronic hit by electronic component shortages

9th Feb 2023 11:19

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday. Read More

Genedrive hearing loss test recommended by UK health department body

9th Feb 2023 10:36

(Alliance News) - Genedrive PLC on Thursday said the UK National Institute for Health & Care Excellence has preliminarily recommended its antibiotic hearing loss test, the MT-RNR1 ID kit. Read More

LONDON MARKET OPEN: BAT falls on sales miss; Entain hit by MGM remark

9th Feb 2023 09:13

(Alliance News) - Stock prices in London opened higher on Thursday, as investors digested a mixed set of UK company earnings. Read More

AIM WINNERS & LOSERS: 88 Energy surges; Petro Matad plans fundraise

3rd Feb 2023 10:26

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday. Read More

IN BRIEF: Genedrive shareholders vote down pre-emption rights power

29th Dec 2022 21:58

Genedrive PLC - Manchester-based molecular diagnostics company - Reports that 21% of its shareholders voted against resolution 3 for the reappointment Tom Lindsay as a director at its annual general meeting on Thursday. 32% of its shareholders voted against resolution 5 for the reappointment of David Budd as a director, and 25% of shareholders voted against resolution 6 for the reappointment of Ian Gilham as a director. Adds that 25% of shareholders voted against resolution 10, to authorise the directors to allot equity securities in the capital. Read More

UK shareholder meetings calendar - next 7 days

22nd Dec 2022 15:44

Genedrive shares slump as loss widens on lack of Covid-19 revenue

21st Nov 2022 12:19

(Alliance News) - Genedrive PLC on Monday reported a substantially widened pretax loss as revenue slumped due to a lack of Covid-19 revenue. Read More

AIM WINNERS & LOSERS: Real Good Food secures turnaround funds

21st Nov 2022 11:15

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More

UK earnings, trading statements calendar - next 7 days

14th Nov 2022 14:32

Genedrive shares surge as pre-submission for MT-RNR1 filed to FDA

5th Oct 2022 11:40

(Alliance News) - Genedrive PLC on Wednesday said it has started engagement with the US Food & Drug Administration to progress the approval of its MT-RNR1 product range into the US. Read More

Genedrive says its "world first" test has been accelerated by NICE

26th Sep 2022 14:24

(Alliance News) - Genedrive PLC on Monday said that its Genedrive MT-RNR1 test has been accelerated by the UK's National Institute for Health & Clinical Excellence. Read More

Genedrive's CYP2C19 ID Kit included in UK's NICE assessment

22nd Aug 2022 11:48

(Alliance News) - Genedrive PLC on Monday said the UK's National Institute for Health & Clinical Excellence has begun an evaluation of CYP2C19 genotype testing for Clopidogrel treatment. Read More

TRADING UPDATES: Valereum opens NFT market; Conygar considers raising

16th Jun 2022 16:55

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

IN BRIEF: Genedrive Covid-19 test receives CTDA approval in UK

30th May 2022 18:14

Genedrive PLC - Manchester-based molecular diagnostics company - Says the UK Medicines & Healthcare Products Regulatory Agency has granted a coronavirus test device approval enabling the sale of the Genedrive COV19-ID Kit in the UK. Genedrive's application for approval was made on December 21. Read More

FTSE 100 Latest

Value9,479.14

Change-12.11